AMGNAmgen

Ranked by relevance and recency.

• 🔥🔥🔥#1Impact1.09%bullishDirectAMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE38d ago

  Repatha could expand into primary prevention, widening its market, though the impact is modest against $36.8B total revenue

  Impact chain →

  Also named: REGN · NVS · ESPR

• 🔥🔥#2Impact0.61%bearish2nd-orderTeva Says Pivot to Growth Gains Steam as Branded Drugs, Biosimilars Outperform24d ago

  Teva's biosimilar gains chip at Amgen's originator biologics franchises, a marginal revenue headwind

  Impact chain →

  Also named: TEVA · VTRS · NVS

• 🔥#3Impact0.29%bearish2nd-orderRevolution Medicines: Strong Buy RASONQUE FDA Approval And Zoldonrasib PDAC Expansions38d ago

  Its Lumakras (sotorasib) faces long-term competition from RVMD's broader RAS(ON) platform, though Lumakras is a small share of Amgen's revenue, limiting the marginal impact.

  Impact chain →

  Also named: RVMD · BMY